EA200600314A1 - Использование растворимого cd164 при воспалительных и/или аутоимунных нарушениях - Google Patents
Использование растворимого cd164 при воспалительных и/или аутоимунных нарушенияхInfo
- Publication number
- EA200600314A1 EA200600314A1 EA200600314A EA200600314A EA200600314A1 EA 200600314 A1 EA200600314 A1 EA 200600314A1 EA 200600314 A EA200600314 A EA 200600314A EA 200600314 A EA200600314 A EA 200600314A EA 200600314 A1 EA200600314 A1 EA 200600314A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- inflammatory
- soluble
- disorders
- automained
- human
- Prior art date
Links
- 101001133085 Homo sapiens Sialomucin core protein 24 Proteins 0.000 title abstract 2
- 230000002757 inflammatory effect Effects 0.000 title abstract 2
- 208000023275 Autoimmune disease Diseases 0.000 abstract 1
- 102000044462 human CD164 Human genes 0.000 abstract 1
- 208000027866 inflammatory disease Diseases 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Cell Biology (AREA)
- Pain & Pain Management (AREA)
- Dermatology (AREA)
- Neurology (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurosurgery (AREA)
- Cardiology (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Transplantation (AREA)
- Pulmonology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Настоящее изобретение относится к новым терапевтическим применениям растворимых белков, содержащих внеклеточную область человеческого CD164, в частности, для лечения воспалительных и/или аутоиммунных нарушений.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03077316 | 2003-07-23 | ||
| PCT/EP2004/051596 WO2005011728A2 (en) | 2003-07-23 | 2004-07-23 | Use of soluble cd164 in inflammatory and/or autoimmune disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EA200600314A1 true EA200600314A1 (ru) | 2006-06-30 |
| EA009389B1 EA009389B1 (ru) | 2007-12-28 |
Family
ID=34112463
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA200600314A EA009389B1 (ru) | 2003-07-23 | 2004-07-23 | Использование растворимого cd164 при воспалительных и/или аутоиммунных нарушениях |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US20060257402A1 (ru) |
| EP (1) | EP1646396A2 (ru) |
| JP (1) | JP4705028B2 (ru) |
| KR (1) | KR20060106810A (ru) |
| CN (1) | CN1845752A (ru) |
| AR (1) | AR045074A1 (ru) |
| AU (1) | AU2004260835A1 (ru) |
| BR (1) | BRPI0412243A (ru) |
| CA (1) | CA2532870A1 (ru) |
| EA (1) | EA009389B1 (ru) |
| IL (1) | IL173197A0 (ru) |
| NO (1) | NO20060781L (ru) |
| RS (1) | RS20060023A (ru) |
| WO (1) | WO2005011728A2 (ru) |
| ZA (1) | ZA200600193B (ru) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2595795A1 (en) | 2005-01-24 | 2006-07-27 | Laboratoires Serono S.A. | Use of soluble cd164 variants in inflammatory and/or autoimmune disorders |
| EA031877B1 (ru) | 2007-02-12 | 2019-03-29 | А1М Фарма Аб | Применение альфа-1-микроглобулина для профилактики или лечения преэклампсии |
| HUE030274T2 (en) * | 2008-07-18 | 2017-05-29 | A1M Pharma Ab | The therapeutic use of the root binding and antioxidant alpha-1 microglobulin |
| US8392585B1 (en) * | 2011-09-26 | 2013-03-05 | Theranos, Inc. | Methods and systems for facilitating network connectivity |
| WO2022099695A1 (en) * | 2020-11-16 | 2022-05-19 | Jiangsu Cell Tech Medical Research Institute Co., Ltd. | Cd164 fusion and uses thereof |
| CN114891107A (zh) * | 2022-05-12 | 2022-08-12 | 北京农学院 | 一种抗猪cd164l2单克隆抗体制备与应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2296792A1 (en) * | 1999-02-26 | 2000-08-26 | Genset S.A. | Expressed sequence tags and encoded human proteins |
| EP1409536A2 (en) * | 2001-02-12 | 2004-04-21 | Curagen Corporation | Human proteins and nucleic acids encoding same |
-
2004
- 2004-07-22 AR ARP040102601A patent/AR045074A1/es not_active Application Discontinuation
- 2004-07-23 AU AU2004260835A patent/AU2004260835A1/en not_active Abandoned
- 2004-07-23 US US10/565,741 patent/US20060257402A1/en not_active Abandoned
- 2004-07-23 WO PCT/EP2004/051596 patent/WO2005011728A2/en active Application Filing
- 2004-07-23 KR KR1020067000284A patent/KR20060106810A/ko not_active Withdrawn
- 2004-07-23 CA CA002532870A patent/CA2532870A1/en not_active Abandoned
- 2004-07-23 EP EP04766309A patent/EP1646396A2/en not_active Withdrawn
- 2004-07-23 RS YUP-2006/0023A patent/RS20060023A/sr unknown
- 2004-07-23 BR BRPI0412243-7A patent/BRPI0412243A/pt not_active IP Right Cessation
- 2004-07-23 EA EA200600314A patent/EA009389B1/ru not_active IP Right Cessation
- 2004-07-23 ZA ZA200600193A patent/ZA200600193B/xx unknown
- 2004-07-23 JP JP2006520839A patent/JP4705028B2/ja not_active Expired - Fee Related
- 2004-07-23 CN CNA2004800253620A patent/CN1845752A/zh active Pending
-
2006
- 2006-01-17 IL IL173197A patent/IL173197A0/en unknown
- 2006-02-17 NO NO20060781A patent/NO20060781L/no not_active Application Discontinuation
-
2008
- 2008-12-22 US US12/341,490 patent/US8075894B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US20090285838A1 (en) | 2009-11-19 |
| JP4705028B2 (ja) | 2011-06-22 |
| WO2005011728A3 (en) | 2005-06-02 |
| NO20060781L (no) | 2006-03-17 |
| ZA200600193B (en) | 2007-04-25 |
| BRPI0412243A (pt) | 2006-09-19 |
| AR045074A1 (es) | 2005-10-12 |
| CA2532870A1 (en) | 2005-02-10 |
| AU2004260835A1 (en) | 2005-02-10 |
| KR20060106810A (ko) | 2006-10-12 |
| EP1646396A2 (en) | 2006-04-19 |
| US20060257402A1 (en) | 2006-11-16 |
| IL173197A0 (en) | 2006-06-11 |
| JP2006528159A (ja) | 2006-12-14 |
| US8075894B2 (en) | 2011-12-13 |
| RS20060023A (en) | 2008-06-05 |
| WO2005011728A2 (en) | 2005-02-10 |
| CN1845752A (zh) | 2006-10-11 |
| EA009389B1 (ru) | 2007-12-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60327999D1 (de) | Azolylaminoazine als inhibitoren von proteinkinasen | |
| EA200700934A1 (ru) | Производные пиримидина и их применение в качестве модуляторов cb2 | |
| DK1368060T3 (da) | HMGB1-proteininhibitorer og/eller antagonister til behandlingen af vaskulære sygdomme | |
| EA201000424A1 (ru) | Антитела к il-23 | |
| DE602004014117D1 (de) | Thiazole zur verwendung als inhibitoren von protein-kinasen | |
| ATE489957T1 (de) | Mittel zur behandlung von entzündlichen erkrankungen | |
| YU37304A (sh) | Specifični agensi koji vezuju humani angiopoetin-2 | |
| BG66084B1 (bg) | Циклопентаноиндоли, състави,съдържащи такива съединения и използването им | |
| EA200800763A1 (ru) | Терапевтические композиции, содержащие гиалуроновую кислоту и терапевтические антитела, а также способы лечения | |
| ATE466580T1 (de) | Azolylaminoazine als proteinkinasehemmer | |
| ATE468336T1 (de) | Azolylaminoazine als proteinkinasehemmer | |
| ATE365733T1 (de) | Zusammensetzungen brauchbar als protein-kinase- inhibitoren | |
| WO2004024097A8 (en) | Compositions and methods for the treatment of immune related diseases | |
| ATE267830T1 (de) | Als cox-hemmer verwendbare sulfonylphenylpyrazol- verbindungen | |
| TW200612905A (en) | Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders | |
| EA200801343A1 (ru) | Иммуноглобулины, направленные против nogo | |
| MY147767A (en) | Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders | |
| DE602004012578D1 (de) | Als inhibitoren von c-met geeignete pyrrolzusammensetzungen | |
| NO20055741L (no) | Nye kjemiske forbindelser | |
| ATE549353T1 (de) | Aktive varianten des il-18 bindenden proteins und dessen medizinische verwendungen | |
| SE0302304D0 (sv) | Novel compounds | |
| EA200501528A1 (ru) | Применение кластерина для лечения и/или профилактики периферических неврологических заболеваний | |
| EA200702634A1 (ru) | Гуманизированные антитела, специфичные в отношении nogo-a, и их фармацевтические применения | |
| NO20060781L (no) | Anvendelse av loselig CD164 ved inflammatoriske og/eller autoimmune lidelser | |
| NO20055563L (no) | Midler for behandlingen av lavere abdominale lidelser |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC4A | Registration of transfer of a eurasian patent by assignment | ||
| MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG MD TJ TM |
|
| MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): RU |